Drug Approval | June 23, 2026
Teva submits FDA application for experimental Tourette syndrome treatment ecopipam
The filing is backed by positive Phase 3 results recently published in JAMA Neurology
The filing is backed by positive Phase 3 results recently published in JAMA Neurology
About 250+ women riders participate in the awareness ride where free breast screening camp were conducted
As per union government, growing public participation reflects rising awareness and collective commitment towards advancing organ and tissue donation
CDMO strengthens global quality framework through digital transformation, AI-enabled investigations, workforce development and continuous audit readiness
Veteran health innovation and policy leader to drive biotechnology innovation, startup growth and commercialization of indigenous technologies
Acquisition of Mumbai-based pharmaceutical, nutraceutical and cosmeceutical company expected to be completed by July 2026
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
The collaboration is focused on overcoming a major limitation in existing cancer drugs
State-of-the-art facility brings next-generation imaging and minimally invasive neurointerventional capabilities to Eastern India
New facility equipped with advanced imaging technology to support 200 additional procedures a month and benefit nearly 3,000 more patients annually
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
